Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
Urticarial vasculitis is characterised by inflamed itching or burning red patches or wheals that resemble urticaria but persist for greater than 24 hours. It is often idiopathic but is sometimes associated with collagen-vascular disease, particularly systemic lupus erythematosus. Treatment options i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Dermatological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2015/576893 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549314110423040 |
|---|---|
| author | Misbah Nasheela Ghazanfar Simon Francis Thomsen |
| author_facet | Misbah Nasheela Ghazanfar Simon Francis Thomsen |
| author_sort | Misbah Nasheela Ghazanfar |
| collection | DOAJ |
| description | Urticarial vasculitis is characterised by inflamed itching or burning red patches or wheals that resemble urticaria but persist for greater than 24 hours. It is often idiopathic but is sometimes associated with collagen-vascular disease, particularly systemic lupus erythematosus. Treatment options include oral antihistamines, oral corticosteroids, dapsone, colchicine or hydroxychloroquine. We describe a male patient with urticarial vasculitis who was treated with omalizumab (anti-IgE) with convincing results and provide a review of previous reports of patients with urticarial vasculitis treated with omalizumab. |
| format | Article |
| id | doaj-art-84a497ef362b4231b4768fd38bcc9a8a |
| institution | Kabale University |
| issn | 2090-6463 2090-6471 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Dermatological Medicine |
| spelling | doaj-art-84a497ef362b4231b4768fd38bcc9a8a2025-02-03T06:11:32ZengWileyCase Reports in Dermatological Medicine2090-64632090-64712015-01-01201510.1155/2015/576893576893Omalizumab for Urticarial Vasculitis: Case Report and Review of the LiteratureMisbah Nasheela Ghazanfar0Simon Francis Thomsen1Department of Dermatology, Bispebjerg Hospital, 2400 Copenhagen NV, DenmarkDepartment of Dermatology, Bispebjerg Hospital, 2400 Copenhagen NV, DenmarkUrticarial vasculitis is characterised by inflamed itching or burning red patches or wheals that resemble urticaria but persist for greater than 24 hours. It is often idiopathic but is sometimes associated with collagen-vascular disease, particularly systemic lupus erythematosus. Treatment options include oral antihistamines, oral corticosteroids, dapsone, colchicine or hydroxychloroquine. We describe a male patient with urticarial vasculitis who was treated with omalizumab (anti-IgE) with convincing results and provide a review of previous reports of patients with urticarial vasculitis treated with omalizumab.http://dx.doi.org/10.1155/2015/576893 |
| spellingShingle | Misbah Nasheela Ghazanfar Simon Francis Thomsen Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature Case Reports in Dermatological Medicine |
| title | Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature |
| title_full | Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature |
| title_fullStr | Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature |
| title_full_unstemmed | Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature |
| title_short | Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature |
| title_sort | omalizumab for urticarial vasculitis case report and review of the literature |
| url | http://dx.doi.org/10.1155/2015/576893 |
| work_keys_str_mv | AT misbahnasheelaghazanfar omalizumabforurticarialvasculitiscasereportandreviewoftheliterature AT simonfrancisthomsen omalizumabforurticarialvasculitiscasereportandreviewoftheliterature |